|
|
.
See Category: Diseases of the digestive system
See Header: Crohn's disease, unspecified, with complications
ICD-10 (CM) Code and Descriptor
|
K50.913 |
Crohn's disease, unspecified, with fistula
|
K50913 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 57.89%
|
18.40%
|
8.83%
|
5.15%
|
2.42%
|
2.63%
|
1.52%
|
0.58%
|
0.58%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K50.913*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
434
|
435
|
|
80053
|
COMPREHEN METABOLIC PANEL |
362
|
362
|
|
96413
|
CHEMO IV INFUSION 1 HR |
279
|
279
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
261
|
263
|
|
83735
|
ASSAY OF MAGNESIUM |
245
|
247
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
221
|
279
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
220
|
12,441
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
216
|
234
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
202
|
203
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
177
|
243
|
|
86140
|
C-REACTIVE PROTEIN |
174
|
174
|
|
84100
|
ASSAY OF PHOSPHORUS |
167
|
167
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
150
|
150
|
|
J1200
|
DIPHENHYDRAMINE HCL INJECTIO |
134
|
309
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
131
|
302
|
|
80048
|
METABOLIC PANEL TOTAL CA |
126
|
126
|
|
J3380
|
INJ VEDOLIZUMAB IV 1 MG |
105
|
31,500
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
84
|
3,164
|
|
J2405
|
ONDANSETRON HCL INJECTION |
82
|
408
|
|
85027
|
COMPLETE CBC AUTOMATED |
79
|
79
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K50.913 related to the following DRG Codes:
385-387
|
